Protalix Biotherapeutics Inc (NYSE American:PLX)

4.50
Delayed Data
As of Jan 20
 -0.01 / -0.22%
Today’s Change
2.04
Today|||52-Week Range
4.87
+23.97%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Schwartz Aharon
Director
Buy4/07/202064,000$2.43$155.5K+87.92%
Bashan Dror
President & Chief Executive Officer
Gift8/11/2020447,927$0.00$0.00+22.89%
Rubin Eyal /brainstorm/
Chief Financial Officer & Senior Vice President
Gift8/11/2020246,146$0.00$0.00+22.89%